We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025

By LabMedica International staff writers
Posted on 06 Nov 2019
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. More...
The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.

Geographically, several macroeconomic factors and internal market forces will shape the growth and development of demand patterns in the emerging countries in Asia-Pacific, Latin America and the Middle East. In North America, the US blood gas and electrolyte analyzers market is expected to grow at a CAGR of 5.5% during the forecast period. Within Europe, Germany is projected to add sales of over USD 64.4 million to the region’s blood gas and electrolyte analyzers market over the next 5 to 6 years. Over USD 55.9 million worth of demand in the region is projected to come from the Rest of Europe markets. In Japan, the Bench Top segment is expected to reach a market size of USD 97.6 million by the end of the forecast period.

The blood gas and electrolyte analyzers market in China, which is the world's second largest-economy and the new game changer in the global markets, is projected to grow at the rate of 9.6% over the next couple of years and add approximately USD 498.3 million in terms of addressable opportunity.



New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Aspiration System
VACUSAFE
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.